Roche Holding AG (RO.SW) is in Healthcare, Drug Manufacturers - General, based in Switzerland, listed on Swiss. Market cap 291.94B CHF. 52-week range 270.80 to 383.00 CHF. Trailing P/E 23.9. Data as of 2026-10-09.
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as ...